New statin guidelines shock even the medical community

The 2026 cholesterol management guideline just published by the American College of Cardiology (ACC) and the American Heart Association (AHA) sent a shockwave through the medical community.

Under these new standards, millions more Americans now fall into the “at-risk” category — making them eligible for cholesterol-lowering drugs… as early as age 30.

While statins are effective and affordable, the prospect of 50+ years of daily medication is a daunting proposition.

Peak PS

It’s a mouthful, but Phosphatidylserine, or PS for short, is a nootropic that promotes brain health, memory, clarity, reasoning and comprehension. This nutrient is a key building block for the cells in your brain, that scientific literature has shown can… MORE⟩⟩

«SPONSORED»

The “Lower for Longer” Goal

The overarching premise of the new guideline is medically sound: Lower LDL, for longer, is better. This is supported by a mountain of consistent data that cannot be ignored.

Per the guideline, we should therefore be aiming for even lower LDLs, approximately 30 points lower than prior guideline goals.  Here are the new targets:

  • LDL < 100 mg/dL for the general population.
  • LDL < 70 mg/dL if other risk factors are present.
  • LDL < 55 mg/dL for those with established heart or vascular disease

By the way, about 50% of US adults — including people in their 30s — have LDL levels above 100 mg/dL.

The 73-to-1 Disparity

The issue isn’t the target; it’s how we get there. The new guidelines are heavily weighted toward drugs rather than root-cause solutions.

Consider this: 73 pages of the document are devoted to pharmacotherapy. How many are devoted to dietary approaches? Three-quarters of one page.

The authors state that lifestyle modifications are “foundational,” yet they dismiss nutrition and claim patients are unlikely to see significant results through diet alone. Supplements? Useless. In essence, the guideline implies that only drugs can move the needle.

Why Nutrition is Sidelined

The medical community worships the Randomized Controlled Trial (RCT) as the gold standard for documenting the effect of an intervention. For good reason. It is the best type of trial to prove — objectively — that something works. Guidelines are therefore based heavily on data derived from RCTs.   

Because RCTs are prohibitively expensive and complex to administer, they are almost exclusively funded by pharmaceutical giants who are interested in proving the effectiveness of their drug, above all else.

This ultimately leads to an intrinsic bias in guideline recommendations. If the recommendations are based on RCT results, disproportionate emphasis will be placed on pharmaceutical solutions, which are… wait for it… studied in RCTs.

Meanwhile, the vast majority of data around nutrition is observational, and the only conclusions that can be made from those types of studies are inferential. Inferential conclusions — even if seen repeatedly — don’t make the cut for guideline purposes.

Which is why, at Step One Foods, we decided to play by medicine’s rules. We conducted our own RCT— supported by the Mayo Clinic and the University of Manitoba — to prove that precise nutrition does work. The results showed that when food is formulated like medicine, it performs like medicine.

Peak Bladder Support

Unique Formula Helps Reduce Urgency or the Immediate Urge to “Go” and Decreases Nighttime Bathroom Visits for More Restful Sleep!

«SPONSORED»

It’s Not “Either-Or” — It’s “Both-And”

Don’t get me wrong: Drugs have a role. They save lives, and as a cardiologist, I prescribe them.

But if we ignore the underlying drivers of high cholesterol, we end up trapped in a cycle of increasing medication dosages to maintain control. And decades of high-dose drug exposure are not necessarily benign.

Cholesterol management should never be a binary choice. You can use Step One products alongside medication to:

  1. Enhance Results: The combination is often more powerful than either intervention alone.
  2. Lower Dosages: Better nutrition may allow you to maintain target LDL levels with lower drug doses, reducing the potential for long-term side effects.

Take Your Power Back

At Step One Foods, we do something unheard of in the food or supplement industry: We encourage you to test. Because not everyone responds to every intervention equally. And we want you to see the impact of our solution on your cholesterol readings for yourself. After all, your health should never be a guessing game — it should be an objective reality. 

So, whether you are 30 years old, holding your first prescription, or 60 years old, looking at a cabinet full of pill bottles, remember this: You have more control over your health than a guideline might lead you to believe.  

Editor’s note: There are perfectly safe and natural ways to decrease your risk of blood clots including the 25-cent vitamin, the nutrient that acts as a natural blood thinner and the powerful herb that helps clear plaque. To discover these and other secrets of long-lived hearts, click here for Hushed Up Natural Heart Cures and Common Misconceptions of Popular Heart Treatments!

Dr. Elizabeth Klodas MD, FACC

By Dr. Elizabeth Klodas MD, FACC

"Diet is a major driver of high cholesterol, but instead of changing the food, we prescribe medications. This never seemed logical to me.” Dr. Klodas has dedicated her career to preventive cardiology. Trained at Mayo Clinic and Johns Hopkins, she is the founder and Chief Medical Officer for Step One Foods. Dr. Klodas is a nationally sought out speaker and has an active role at the American College of Cardiology. Her clinical interests include prevention of heart disease and non-invasive cardiac imaging and she has published dozens of scientific articles throughout her career. Dr. Klodas has been featured on CNN Health for her mission to change how heart disease is treated. An independent study performed at leading medical institutions affirmed the ability of Step One Foods to deliver measurable and meaningful cholesterol-reduction benefits in the real world. The results of the trial were presented at the 2018 American Heart Association’s Scientific Sessions. Dr. Klodas has also authored a book for patients, "Slay the Giant: The Power of Prevention in Defeating Heart Disease," and served as founding Editor-in-Chief of the patient education effort of the American College of Cardiology. In addition to her practice and her duties at Step One Foods, she also serves as medical editor for webMD.

«SPONSORED»